# TIcagrelor in Rotational Atherectomy to Reduce TROPonin Enhancement

Study · id `cardio:ct-nct02505399` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02505399](<https://clinicaltrials.gov/study/NCT02505399>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT02505399

Browse, organ or system: Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 180 participants.

## Technical summary

Registry record NCT02505399. Randomized; double masking; primary purpose prevention. Start 2015-11 (registry gives no type); primary completion 2018-05-24 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose prevention
- Phase: Phase 4
- Enrolled: 180 participants (enrolled count; ClinicalTrials.gov record NCT02505399, source copy `cardio:ctgov-nct02505399-2026-06-01`, retrieved 2026-10-31)
- Start date: 2015-11 (registry gives no type) (ClinicalTrials.gov record NCT02505399, source copy `cardio:ctgov-nct02505399-2026-06-01`, retrieved 2026-10-31)
- Primary completion: 2018-05-24 (actual) (ClinicalTrials.gov record NCT02505399, source copy `cardio:ctgov-nct02505399-2026-06-01`, retrieved 2026-10-31)
- Completion: 2018-05-30 (actual) (ClinicalTrials.gov record NCT02505399, source copy `cardio:ctgov-nct02505399-2026-06-01`, retrieved 2026-10-31)
- Countries: France (ClinicalTrials.gov record NCT02505399, source copy `cardio:ctgov-nct02505399-2026-06-01`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02505399-2026-06-01`, retrieved 2026-10-31)

## The registry's words

- Brief title: TIcagrelor in Rotational Atherectomy to Reduce TROPonin Enhancement
- Acronym: TIRATROP
- Condition: Atherosclerosis
- Intervention (Drug): ticagrelor
- Intervention (Drug): clopidogrel
- Lead sponsor: University Hospital, Toulouse
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Atherosclerosis (`cardio:atherosclerosis`)
- Registry intervention name matches this record: Ticagrelor (`cardio:ticagrelor`)
- Registry intervention name matches this record: Clopidogrel (`cardio:clopidogrel`)
- Registry intervention is a member of this class by a sourced record link: P2Y12 inhibitors (drug class) (`cardio:p2y12-inhibitors`)
- Registry lists this organization as the lead sponsor: University Hospital, Toulouse (`cardio:org-university-hospital-toulouse`)

## Provenance

Content hash: 392b4ba6c93ddf242790c5f8ff778f4944b6e40f2c9c9f20a84bc6a4eff966df
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
